Table 2.
Summary of researches on EVs involved in in vivo wound repair
Wound type | Animal model | EVs type | Cargo | Target | Function | References |
---|---|---|---|---|---|---|
Acute wound | Rat model of the skin-deep second-degree burn wound | HucMSC-derived EVs (30–100 nm) | – | Wnt/β-catenin | Proangiogenic effect↑ | [94] |
Rat skin burn model | HucMSC-derived EVs | – | Wnt4 | Heat stress-induced apoptosis↓ | [95] | |
Deep second-degree burn mice model | Blue light-treated MSC-derived EVs |
miR-135b-5p miR-499a-3p |
MEF2C | Proangiogenic ability↑ | [89] | |
Severe burn rat model | HucMSC-derived EVs | miR-181c | Toll-like receptor 4 | Burn-induced inflammation↓ | [96] | |
Rat full-thickness cutaneous wounds model | UCB-MSC-derived EVs |
miR-21-5p miR-125b-5p |
TGF-β receptor type II and TGF-β receptor type I | Anti-myofibroblast differentiation↑ | [91] | |
Mouse full-thickness cutaneous wounds model | UCMSC-derived EVs (75.66 nm) | – | – |
Recruitment of fibroblasts↑ Cutaneous nerve regeneration↑ |
[97] | |
Mouse full-thickness skin defects model | HucMSC-derived EVs (85% range from 20 to 200 nm) | – |
Inhibiting nuclear translocation of apoptosis-inducing factor Upregulating poly ADP ribose polymerase 1 (PARP-1) and poly (ADP-ribose) |
Epidermal re-epithelialization↑ Dermal angiogenesis↑ |
[98] | |
Mouse skin wound model | BMSCs overexpressed with miR-126 EVs (Exo-miR-126, 30–200 nm) | miR-126 | Targeting phosphoinositol-3 kinase regulatory subunit 2 to activate the PI3K/Akt signalling pathway | Newly formed capillaries↑ | [24] | |
Rat skin wound model | hiPSC-MSC-derived EVs | – | – |
Collagen synthesis↑ Angiogenesis↑ |
[47] | |
Rat skin wound model | HucMSC-derived EVs | 14-3-3ζ proteins | Wnt/β-catenin signaling | Cutaneous regeneration | [99] | |
Mouse retinal laser injury wound model | HucMSC-derived EVs (40–100 nm) | – | Downregulation of monocyte chemotactic protein-1 |
Apoptosis↓ Inflammatory responses↓ |
[100] | |
Mouse full-thickness dermal wound injury model | FDMSC-derived EVs | – | Notch signaling pathway by Jagged 1 | Adult dermal fibroblast cell motility and secretion ability↑ | [101] | |
Mouse full-thickness dorsal wound model | ADMSC-derived EVs | – | Regulating the ratios of collagen type III to type I, TGF-β3 to TGF-β1 and MMP-3 to TIMP-1 | ECM reconstruction↑ | [102] | |
Mouse full-thickness dorsal wound model | ADMSC-derived EVs | miR-125a-3p | PTEN | Angiogenesis↑ | [103] | |
Corneal epithelial wound model | HucMSC-derived EVs | miR-21 |
PTEN PI3K/Akt signaling pathway |
Corneal wound repair↑ | [104] | |
Mouse excisional full-thickness wound model | ADMSC-derived EVs (113.6 nm) | miR-192-5p | miR-192-5p/IL-17RA/Smad axis | Anti-fibrotic properties↑ | [105] | |
Mouse full-thickness skin wound model | TSG-6 overexpressed MSC-derived EVs | – | – |
Scar pathological injury↓ Collagen deposition↓ |
[106] | |
Mouse full-thickness wound model | ADMSC-derived EVs | – | – |
Collagen expression↓ Scar formation↓ |
[107] | |
Mouse skin-defective wound model | BMSC-derived EVs (20–200 nm) | miR-223 | PKNOX1 | M2 polarization of macrophages | [108] | |
Mouse full-thickness skin defect model | HucMSC-derived EVs (30–150 nm) |
miR-21 miR-23a miR-125b miR-145 |
Transforming growth factor-β/Smad2 signaling pathway | Myofibroblast formation↓ | [109] | |
Murine hind limb ischemia model | EVs released from hP-MSCs by NO stimulation |
VEGF miR-126 |
– | Angiogenic processes↑ | [110] | |
Diabetic rat wound model | ATV pretreated BMSC (ATV-derived EVs, 80–120 nm) | miR-221-3p | Akt/eNOS signaling pathway | Angiogenesis effect↑ | [111] | |
Chronic wound | Diabetic rat wound model | HucMSC-derived EVs (30–150 nm) | – | – | VEGF and TGF-β1↑ | [112] |
Diabetic mouse cutaneous wound model | HucMSC-derived EVs (30–150 nm) | – | – |
Oxidative stress↓ Angiogenesis↑ |
[113] | |
Eczema mouse wound model | MSC-derived EVs | – | – |
Inflammatory cell infiltration↓ Vascular formation↑ |
[114] | |
Diabetic mouse wound model | Hypoxic ADMSC-derived EVs |
Upregulated miR-21-3p, miR-126-5p, miR-31-5p Downregulated miR-99b and miR-146-a |
PI3K/Akt signaling pathway |
Diabetic wounds healing↑ Inflammation↓ |
[115] | |
Diabetic rat cutaneous wound model | LPS‐preconditioning of HucMSC-derived EVs (40–90 nm) | let-7b | let-7b/TLR4 pathway[116] | Regulatory abilities for macrophage polarization | [116] | |
AD-like chronic allergic dermatitis mouse model | ADMSC-derived EVs | – | Facilitating the de novo synthesis of ceramides | Epidermal barrier functions↑ | [117] | |
Rat diabetic foot ulcers model | Linc00511-overexpressing ADMSC-derived EVs | – | Suppressing PAQR3-induced Twist1 ubiquitin degradation | Angiogenesis↑ | [118] | |
Diabetic rat wound model |
hBMSC-derived EVs hBMSC-MT-derived EVs (30–150 nm) |
– | PTEN/Akt pathway | Regulating macrophage M1 and M2 polarization | [26] | |
SD rat skin photoaging model | ADMSC-derived EVs (30–150 nm) | – | – |
Type I collagen↑ Type III collagen, MMP-1, and MMP-3↓ |
[119] | |
Wound model | ADMSCs overexpressing Nrf2-EVs | – | – |
Granulation tissue formation↑ Angiogenesis↑ Growth factor expression↑ Oxidative stress-related proteins↓ |
[120] | |
Diabetic mouse cutaneous wound model | BMSC-derived EVs (50–150 nm) | lncRNA KLF3-AS1 | miR-383, VEGFA | Angiogenesis↑ | [121] | |
Diabetic rat wound model | BMSCs preconditioned by deferoxamine-derived EVs (50–150 nm) | miR-126 |
PTEN PI3K/Akt signaling pathway |
Wound healing↑ Angiogenesis↑ |
[122] | |
HucMSC-derived EVs (40–100 nm) | – | Downregulation of monocyte chemotactic protein-1 |
Apoptosis↓ Inflammatory responses↓ |
[100] |
EVs extracellular vesicles, HucMSC human umbilical cord mesenchymal stem cell, MSC mesenchymal stem cell, UCB-MSC umbilical cord blood mesenchymal stem cell, UCMSC umbilical cord mesenchymal stem cell, ADP adenosine diphosphate, BMSC bone marrow mesenchymal stem cell, Exo exosome, hiPSC human-induced pluripotent stem cells, FDMSC fetal dermal mesenchymal stem cell, ADMSC adipose-derived mesenchymal stem cell, MMP matrix metalloproteinases, PTEN phosphatase and tensin homolog deleted on chromosome 10, TSG-6 tumor necrosis factor alpha-stimulated gene 6, PKNOX1 homo sapiens PBX/knotted 1 homeobox 1, Smad Drosophila mothers against decapentaplegic proteins, hP-MSC human placenta-derived mesenchymal stem cell, ATV atorvastatin, LPS lipopolysaccharide, PAQR3 progestin and adipoQ receptor 3, hBMSC human bone marrow mesenchymal stem cell, IL interleukin, VEGFA vascular endothelial growth factor A, eNOS endothelial nitric oxide synthase, TLR toll-like receptor, AD atopic dermatitis